(Last updated : 2020-01-20 14:02:33)
  黒瀬 浩史
   Department     ,
   Position  
■ BooK
1. 2013/09   Anti-CCR4 mAb and Regulatory T Cells「癌と化学療法」 
■ Journal
1. 2017/12 Nivolumab-induced polyarthritis 
2. 2017/03 NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC. 
3. 2016/12 Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells. 
4. 2015/09 Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients. 
5. 2015/01 Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an anti-human CCR4 mAb (KM2760).  Link
Display all(11)
■ Presentation
1. 2015/09/26 Discriminant function for predicting survival of lung adenocarcinoma patients developed by using immune parameters of PD-L1,Gal-9, and XAGE1 expression on tumor cells and T cell infiltration score.  
2. 2015/09/26 Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody,  
3. 2015/04/17 Clinical effect of XAGE1(GAGED2a) antigen expression and antibody response in EGFR mutated and wild-type advanced lung adenocarcinoma  
4. 2014/10/05 Clinical effect of XAGE1 (GAGED2a) antigen expression and antibody response in EGFR mutated and wild-type advanced lung adenocarcinoma  
5. 2014/10/05 Increase of activated Tregs in TIL in lung cancer and in vitro depletion of Tregs by ADCC using anti-human CCR4 mAb (KM2760)  
Display all(12)
■ Belonging society
1. 2010/01~ American Association for Cancer Research